US Stock MarketDetailed Quotes

Celldex Therapeutics (CLDX)

Watchlist
  • 33.455
  • -0.405-1.20%
Trading May 6 10:02 ET
2.63BMarket Cap-8.58P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Celldex Therapeutics (CLDX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-33.70%-210.95M
-96.88%-63.94M
12.12%-48.63M
-50.05%-44.01M
-33.80%-54.37M
-47.06%-157.78M
0.18%-32.48M
-191.35%-55.34M
-7.84%-29.33M
-42.25%-40.64M
Net income from continuing operations
-63.91%-258.76M
-72.68%-81.32M
-59.17%-67.04M
-57.92%-56.6M
-63.97%-53.8M
-11.62%-157.86M
-8.74%-47.09M
-10.09%-42.12M
-17.51%-35.84M
-11.74%-32.81M
Operating gains losses
-25.00%12K
--0
50.00%6K
--2K
-50.00%4K
--16K
--4K
--4K
--0
--8K
Depreciation and amortization
6.39%3.38M
-0.37%816K
4.83%824K
9.54%873K
11.87%867K
5.62%3.18M
7.91%819K
2.48%786K
5.42%797K
6.75%775K
Change In working capital
165.08%14.06M
15.70%8.53M
150.81%9.8M
49.65%4.22M
32.04%-8.5M
-260.46%-21.6M
48.08%7.38M
-248.34%-19.29M
286.99%2.82M
-314.25%-12.5M
-Change in receivables
-168.21%-1.32M
-1,366.45%-1.93M
--0
-14.34%974K
-746.51%-364K
184.52%1.93M
106.40%152K
608.96%682K
-4.93%1.14M
95.55%-43K
-Change in prepaid assets
143.78%8.71M
11,347.30%8.47M
80.59%-2.79M
94.99%1.17M
129.83%1.85M
-437.07%-19.89M
-98.21%74K
-889.38%-14.35M
121.52%599K
-328.10%-6.21M
-Change in payables and accrued expense
-5.18%11.03M
-42.44%4.6M
94.75%13.06M
21.70%2.09M
-82.35%-8.72M
23.98%11.63M
106.19%7.99M
-20.88%6.71M
258.58%1.71M
-38.66%-4.78M
-Change in other current assets
62.54%-3.61M
---3.99M
99.34%-64K
--1.11M
---662K
-321,233.33%-9.64M
--0
---9.64M
--0
--0
-Change in other current liabilities
86.64%-753K
263.63%1.38M
84.76%-410K
-77.22%-1.12M
58.88%-604K
-1,319.91%-5.64M
-27.30%-844K
-194.59%-2.69M
-60.00%-632K
-10.87%-1.47M
Cash from discontinued investing activities
Operating cash flow
-33.70%-210.95M
-96.88%-63.94M
12.12%-48.63M
-50.05%-44.01M
-33.80%-54.37M
-47.06%-157.78M
0.18%-32.48M
-191.35%-55.34M
-7.84%-29.33M
-42.25%-40.64M
Investing cash flow
Cash flow from continuing investing activities
172.06%209.07M
130.49%55.43M
27.41%60.85M
206.69%49.85M
113.63%42.95M
-174.27%-290.13M
114.05%24.05M
310.08%47.76M
-4,114.00%-46.72M
-699.61%-315.21M
Net PPE purchase and sale
-41.43%-2.71M
-69.44%-1.28M
19.27%-440K
-165.69%-728K
22.97%-265K
-5.56%-1.92M
-13.51%-756K
-247.13%-545K
33.17%-274K
41.20%-344K
Net investment purchase and sale
173.48%211.79M
128.63%56.71M
26.88%61.29M
208.89%50.58M
113.72%43.22M
-177.22%-288.21M
114.55%24.8M
309.24%48.3M
-3,051.02%-46.45M
-692.37%-314.87M
Cash from discontinued investing activities
Investing cash flow
172.06%209.07M
130.49%55.43M
27.41%60.85M
206.69%49.85M
113.63%42.95M
-174.27%-290.13M
114.05%24.05M
310.08%47.76M
-4,114.00%-46.72M
-699.61%-315.21M
Financing cash flow
Cash flow from continuing financing activities
-99.46%2.39M
249.48%1.35M
-37.53%774K
-98.30%63K
-99.95%202K
102.07%441.45M
-99.82%386K
382.10%1.24M
2,690.98%3.71M
62,740.35%436.11M
Net common stock issuance
--0
--0
--0
--0
--0
99.93%432.3M
--0
--0
--0
--432.3M
Proceeds from stock option exercised by employees
-73.90%2.39M
249.48%1.35M
-37.53%774K
-98.30%63K
-94.70%202K
309.26%9.15M
-66.49%386K
382.10%1.24M
2,690.98%3.71M
449.57%3.81M
Cash from discontinued financing activities
Financing cash flow
-99.46%2.39M
249.48%1.35M
-37.53%774K
-98.30%63K
-99.95%202K
102.07%441.45M
-99.82%386K
382.10%1.24M
2,690.98%3.71M
62,740.35%436.11M
Net cash flow
Beginning cash position
-18.55%28.36M
-0.99%36.04M
-46.08%23.04M
-85.11%17.14M
-18.55%28.36M
18.30%34.81M
72.23%36.4M
51.43%42.74M
112.62%115.08M
18.30%34.81M
Current changes in cash
107.97%515K
10.90%-7.17M
304.94%12.99M
108.17%5.91M
-113.98%-11.22M
-219.93%-6.46M
-158.79%-8.04M
10.58%-6.34M
-179.31%-72.34M
225.03%80.26M
End cash Position
1.82%28.87M
1.82%28.87M
-0.99%36.04M
-46.08%23.04M
-85.11%17.14M
-18.55%28.36M
-18.55%28.36M
72.23%36.4M
51.43%42.74M
112.62%115.08M
Free cash flow
-33.79%-213.66M
-96.26%-65.22M
12.19%-49.07M
-51.12%-44.73M
-33.32%-54.64M
-46.36%-159.7M
-0.10%-33.23M
-191.81%-55.88M
-7.23%-29.6M
-40.57%-40.98M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -33.70%-210.95M-96.88%-63.94M12.12%-48.63M-50.05%-44.01M-33.80%-54.37M-47.06%-157.78M0.18%-32.48M-191.35%-55.34M-7.84%-29.33M-42.25%-40.64M
Net income from continuing operations -63.91%-258.76M-72.68%-81.32M-59.17%-67.04M-57.92%-56.6M-63.97%-53.8M-11.62%-157.86M-8.74%-47.09M-10.09%-42.12M-17.51%-35.84M-11.74%-32.81M
Operating gains losses -25.00%12K--050.00%6K--2K-50.00%4K--16K--4K--4K--0--8K
Depreciation and amortization 6.39%3.38M-0.37%816K4.83%824K9.54%873K11.87%867K5.62%3.18M7.91%819K2.48%786K5.42%797K6.75%775K
Change In working capital 165.08%14.06M15.70%8.53M150.81%9.8M49.65%4.22M32.04%-8.5M-260.46%-21.6M48.08%7.38M-248.34%-19.29M286.99%2.82M-314.25%-12.5M
-Change in receivables -168.21%-1.32M-1,366.45%-1.93M--0-14.34%974K-746.51%-364K184.52%1.93M106.40%152K608.96%682K-4.93%1.14M95.55%-43K
-Change in prepaid assets 143.78%8.71M11,347.30%8.47M80.59%-2.79M94.99%1.17M129.83%1.85M-437.07%-19.89M-98.21%74K-889.38%-14.35M121.52%599K-328.10%-6.21M
-Change in payables and accrued expense -5.18%11.03M-42.44%4.6M94.75%13.06M21.70%2.09M-82.35%-8.72M23.98%11.63M106.19%7.99M-20.88%6.71M258.58%1.71M-38.66%-4.78M
-Change in other current assets 62.54%-3.61M---3.99M99.34%-64K--1.11M---662K-321,233.33%-9.64M--0---9.64M--0--0
-Change in other current liabilities 86.64%-753K263.63%1.38M84.76%-410K-77.22%-1.12M58.88%-604K-1,319.91%-5.64M-27.30%-844K-194.59%-2.69M-60.00%-632K-10.87%-1.47M
Cash from discontinued investing activities
Operating cash flow -33.70%-210.95M-96.88%-63.94M12.12%-48.63M-50.05%-44.01M-33.80%-54.37M-47.06%-157.78M0.18%-32.48M-191.35%-55.34M-7.84%-29.33M-42.25%-40.64M
Investing cash flow
Cash flow from continuing investing activities 172.06%209.07M130.49%55.43M27.41%60.85M206.69%49.85M113.63%42.95M-174.27%-290.13M114.05%24.05M310.08%47.76M-4,114.00%-46.72M-699.61%-315.21M
Net PPE purchase and sale -41.43%-2.71M-69.44%-1.28M19.27%-440K-165.69%-728K22.97%-265K-5.56%-1.92M-13.51%-756K-247.13%-545K33.17%-274K41.20%-344K
Net investment purchase and sale 173.48%211.79M128.63%56.71M26.88%61.29M208.89%50.58M113.72%43.22M-177.22%-288.21M114.55%24.8M309.24%48.3M-3,051.02%-46.45M-692.37%-314.87M
Cash from discontinued investing activities
Investing cash flow 172.06%209.07M130.49%55.43M27.41%60.85M206.69%49.85M113.63%42.95M-174.27%-290.13M114.05%24.05M310.08%47.76M-4,114.00%-46.72M-699.61%-315.21M
Financing cash flow
Cash flow from continuing financing activities -99.46%2.39M249.48%1.35M-37.53%774K-98.30%63K-99.95%202K102.07%441.45M-99.82%386K382.10%1.24M2,690.98%3.71M62,740.35%436.11M
Net common stock issuance --0--0--0--0--099.93%432.3M--0--0--0--432.3M
Proceeds from stock option exercised by employees -73.90%2.39M249.48%1.35M-37.53%774K-98.30%63K-94.70%202K309.26%9.15M-66.49%386K382.10%1.24M2,690.98%3.71M449.57%3.81M
Cash from discontinued financing activities
Financing cash flow -99.46%2.39M249.48%1.35M-37.53%774K-98.30%63K-99.95%202K102.07%441.45M-99.82%386K382.10%1.24M2,690.98%3.71M62,740.35%436.11M
Net cash flow
Beginning cash position -18.55%28.36M-0.99%36.04M-46.08%23.04M-85.11%17.14M-18.55%28.36M18.30%34.81M72.23%36.4M51.43%42.74M112.62%115.08M18.30%34.81M
Current changes in cash 107.97%515K10.90%-7.17M304.94%12.99M108.17%5.91M-113.98%-11.22M-219.93%-6.46M-158.79%-8.04M10.58%-6.34M-179.31%-72.34M225.03%80.26M
End cash Position 1.82%28.87M1.82%28.87M-0.99%36.04M-46.08%23.04M-85.11%17.14M-18.55%28.36M-18.55%28.36M72.23%36.4M51.43%42.74M112.62%115.08M
Free cash flow -33.79%-213.66M-96.26%-65.22M12.19%-49.07M-51.12%-44.73M-33.32%-54.64M-46.36%-159.7M-0.10%-33.23M-191.81%-55.88M-7.23%-29.6M-40.57%-40.98M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.62%
Sample Name
Sample Code
 +12.87%
Sample Name
Sample Code
 +10.12%
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+8.56%
5
United States Oil Fund LP
USO
+8.33%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +23.80%
Sample Name
Sample Code
 +17.80%
Sample Name
Sample Code
 +15.47%
4
Baidu
BIDU
+11.27%
5
ASE Technology
ASX
+9.91%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to the latest report by AXIOS, the US expects Iran to respond on several key issues within the next 48 hours. No agreement has bee Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -